VCYT - ベラサイト （Veracyte Inc.）

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate in two upcoming investor conferences. Cowen’s 43rd Annual Health Care Conference – Boston, MA Presentation on March 7th at 9:50 a.m. Eastern Time KeyBanc Virtual Life Sciences & MedTech Investor Forum Fireside Chat on March 21st at 3:45 p.m. Eastern Time Live audio webcasts of the company’s pre

Veracyte Inc. (NASDAQ:VCYT) closed Thursday at $23.93 per share, up from $23.90 a day earlier. While Veracyte Inc. has overperformed by 0.13%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VCYT fell by -3.51%, with highs and lows ranging from $32.40 to $14.85, whereas the simple […]

https://www.investing.com/news/pro/veracyte-inc-pt-raised-to-35-at-scotiabank-432SI-3013956

Veracyte Inc. (NASDAQ:VCYT)’s traded shares stood at 1.24 million during the last session, with the company’s beta value hitting 1.44. At the close of trading, the stock’s price was $23.90, to imply an increase of 5.19% or $1.18 in intraday trading. The VCYT share’s 52-week high remains $32.40, putting it -35.56% down since that peak … Veracyte Inc. (NASDAQ: VCYT) Stock Has Dropped -9.19% Over The Month – Is There Room For Growth? Read More »

https://www.investing.com/news/pro/veracyte-inc-pt-raised-to-34-at-needham--company-432SI-3012126

The share price of Veracyte Inc. (NASDAQ:VCYT) rose to $23.77 per share on Wednesday from $22.65. While Veracyte Inc. has overperformed by 4.94%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VCYT fell by -44.08%, with highs and lows ranging from $42.43 to $14.85, whereas the […]

Veracyte Inc. (NASDAQ:VCYT) marked $26.51 per share on Tuesday, up from a previous closing price of $26.43. While Veracyte Inc. has overperformed by 0.30%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VCYT fell by -35.45%, with highs and lows ranging from $45.34 to $14.85, whereas […]

Data published in JCEM demonstrate strong real-world performance of Veracyte’s Afirma GSC in thyroid cancer diagnosis

During the recent session, Veracyte Inc. (NASDAQ:VCYT)’s traded shares were 0.44 million, with the beta value of the company hitting 1.39. At the last check today, the stock’s price was $27.58, reflecting an intraday gain of 2.64% or $0.71. The 52-week high for the VCYT share is $45.58, that puts it down -65.26 from that … The Veracyte Inc. (NASDAQ: VCYT) Stock Dropped 7.65% In A Single Month – Are There Any Hopes For A Gain? Read More »

In Tuesday’s session, Veracyte Inc. (NASDAQ:VCYT) marked $27.25 per share, up from $27.17 in the previous session. While Veracyte Inc. has overperformed by 0.29%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VCYT fell by -27.53%, with highs and lows ranging from $45.58 to $14.85, whereas […]

Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the third quarter of 2022 after the close of market on Wednesday, November 2, 2022. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. The conference call will be webcast live from the company’s

Veracyte Inc. (NASDAQ:VCYT) has a beta value of 1.25 and has seen 1.03 million shares traded in the last trading session. The company, currently valued at $1.17B, closed the last trade at $15.59 per share which meant it lost -$0.49 on the day or -3.05% during that session. The VCYT stock price is -247.21% off … Why Do Investors Buy Stock In Veracyte Inc. (VCYT)? Read More »

Veracyte Inc. (NASDAQ:VCYT) marked $18.63 per share on Tuesday, up from a previous closing price of $17.09. While Veracyte Inc. has overperformed by 9.01%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VCYT fell by -56.88%, with highs and lows ranging from $54.13 to $14.85, whereas […]

Veracyte Inc. (NASDAQ:VCYT) price closed lower on Tuesday, September 27, dropping -2.08% below its previous close. A look at the daily price movement shows that the last close reads $17.31, with intraday deals fluctuated between $16.77 and $18.1299. The company’s 5Y monthly beta was ticking 0.98. Taking into account the 52-week price action we note … Veracyte Inc. (NASDAQ: VCYT) Stock Forecast: Bearish Sentiment Portends -82.89% Downside In 2022 Read More »

As of Monday, Veracyte Inc.’s (NASDAQ:VCYT) stock closed at $17.31, up from $16.58 the previous day. While Veracyte Inc. has overperformed by 4.40%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VCYT fell by -64.59%, with highs and lows ranging from $54.13 to $14.85, whereas the […]